FDA recently announced that it is requiring label changes for opioid pain medicines and medicines used to treat opioid use disorder (OUD).
Updated labels for the prescription drugs will need to say,...
Thermo Fisher Scientific and Lyell Immunopharma recently partnered to develop manufacturing processes create more effective cell therapies to benefit cancer patients.
The companies main goal is to...
Among FDA approval packages for novel therapeutic agents from 2011 and 2015, disagreements were common over new drug approvals, populations indicated, and the specific parameters of the approval,...
Roche recently announced that the Phase III COVACTA trial of its rheumatoid arthritis (RA) drug, Actemra/RoActemra, did not meet its primary endpoint of improved clinical status in patients with severe...
The Trump administration is aiming to lower drug prices by eliminating kickbacks to middlemen, like pharmacy benefit managers (PBMs), and increasing drug importation in three new executive orders...
Direct-acting antivirals (DAA) could be the answer in treating patients with hepatitis C viral (HCV) infections, regardless of whether they also suffer from cirrhosis, according to a JAMA Network Open...
GSK and CureVac recently announced a collaboration for the research, development, manufacturing, and commercialization of five mRNA-based vaccines and monoclonal antibodies (mAbs) targeting infectious...
Biogen and The Alzheimer’s Clinical Trials Consortium recently announced the start of a Phase 3 clinical study of BAN2401, an antibody for individuals with preclinical Alzheimer’s...
A recent clinical trial found that a new COVID-19 vaccine candidate, ChAdOx1 nCoV-19, given as a single dose was safe and well tolerated, according to a new study published in Lancet.
For more...
In patients with Alzheimer’s disease, a daily dose of dopamine agonist, rotigotine, showed no significant benefit from baseline to 24 weeks when compared with a placebo, according to a JAMA...
Microsoft and C.H. Robinson recently partnered to transform supply chains of the future and enable real-time visibility for C.H. Robinson customers.
To meet the demands of evolving global supply...
Gilead recently reported additional data on remdesivir, an investigational antiviral for the treatment of COVID-19.
For more coronavirus updates, visit our resource page, updated twice...
Abbott and Tandem Diabetes Care (NASDAQ:TNDM) recently announced a finalized agreement to develop and commercialize integrated diabetes management solutions to improve care for patients living...
FDA recently announced that GSK Consumer Healthcare voluntarily recalled two lots of Children’s Robitussin and one lot of Children’s Dimetapp due to the inclusion of incorrect dosing...
Walmart recently announced that it acquired specific assets of CareZone, a pharmacy management app that allows patients and families to manage medications as well as physician...
The World Health Organization (WHO) temporarily paused the use of hydroxychloroquine (HCQ) in its Solidarity trial based on study results which showed the drug was not effective in treating...
New data from real-world evidence suggests that simultaneous insulin and GLP-1 RA therapies could provide more effective blood sugar control in patients with uncontrolled type 2 diabetes.
Researchers...
AstraZeneca recently partnered with Accent Therapeutics to discover, develop, and commercialize novel cancer therapeutics targeting RNA-modifying proteins (RMPs).
The companies will focus on targeting...
FDA recently revoked the Emergency Use Authorization (EUA) for chloroquine phosphate (CQ) and hydroxychloroquine sulfate (HCQ), according to an official announcement.
For more coronavirus updates,...
Medicaid spent an estimated $761 million in excess costs over seven years due to delayed generic drug entry costs, according to a recent study.
Delayed generic drug entry is common,...
